Having more refined mouse models of metabolic dysfunction-associated steatotic liver disease (MASLD; also known as nonalcoholic fatty liver disease) will help to advance research into this disease.

Non-alcoholic fatty liver disease (NAFLD) is the most prevalent cause of liver disease worldwide. NAFLD is commonly associated with the metabolic syndrome ('Metabolic NAFLD' and predisposes to more ...

Major barriers in screening for fatty liver disease in patients with HIV included uncertainties about testing, diagnostic ...

Robust microbiome signatures enable more precise diagnoses and open up new therapeutic approaches for the treatment of NAFLD ...

Actor Amitabh Bachchan advocates for a national campaign against non-alcoholic fatty liver disease, highlighting its severity ...

It is the progressive form of non-alcoholic fatty liver disease (NAFLD). NASH can lead to cirrhosis and liver cancer. The gut–liver axis is of crucial importance in health and disease.

Alcohol-related liver disease (ARLD) is a serious health problem worldwide. Drinking too much alcohol can damage the liver, a ...

alcoholic liver disease, and non-alcoholic fatty liver disease, and were validated in two independent groups including a prospective one. Steatosis was blindly assessed by using a previously ...

New Delhi, A recent AIIMS study, which analysed published reports on non-alcoholic fatty liver disease in India, states that over one-third (38 per cent) of Indians have fatty liver or non ...

also known as non-alcoholic fatty liver disease (NAFLD). According to the NHS, NAFLD can increase the risk of serious health problems, including diabetes, high blood pressure and kidney disease.